Clinical Trials Logo

Filter by:
NCT ID: NCT02733211 Withdrawn - Type 1 Diabetes Clinical Trials

Cross-over Study to Evaluate the Safety and Efficacy of Night Closed-loop Control Using the MD-Logic Automated Insulin Delivery System Compared to Sensor Augmented Pump Therapy in Poorly Controlled Patients With Type 1 Diabetes

Start date: March 2019
Phase: N/A
Study type: Interventional

The MD-Logic Automated Insulin Delivery System is intended for patients with type 1 diabetes mellitus for subcutaneous infusion of insulin and the continuous measurement of interstitial glucose to aid in the management of their diabetes. The product automatically adjusts basal insulin delivery and delivers correction boluses in response to real-time glucose measurements by CGM to maintain blood glucose within the desired range, to improve metabolic control without increasing the risk of hypoglycemia. The proposed study is an open-label, two-center, randomized, cross-over study to evaluate the safety and efficacy of night closed-loop control using the MD-Logic automated insulin delivery system compared to sensor augmented pump therapy in poorly controlled patients with type 1 diabetes at home The objective of this pilot study is to evaluate the safety and efficacy of 4 weeks glucose control using the MD-Logic System in individuals with poorly controlled type 1 diabetes at patient's home

NCT ID: NCT02732535 Enrolling by invitation - Clinical trials for Natural Killer Cell Deficiency, Familial Isolated

Natural Killer (NK) Cells Following Bariatric Surgery

Start date: August 2015
Phase: N/A
Study type: Observational [Patient Registry]

This study will determine the role of the NK cells before and after bariatric surgery. The investigators selected patients with NAFLD. A Fibroscan evaluation will be assessed as a new modality to evaluate liver fibrosis.

NCT ID: NCT02731989 Recruiting - Undescended Testis Clinical Trials

Comparison Between the Clinical Assessment of the Undescended Testis and Its' Ultrasonographic Size

Start date: July 24, 2017
Phase: N/A
Study type: Observational

In addition to the manual preoperative examination, the undescended testicle will be measured ultrasonographically. The compared data will help us to evaluate the routine need for preoperative ultrasonographic evaluation of the undescended testicle.

NCT ID: NCT02731781 Not yet recruiting - Clinical trials for TO FIND THE CORRELATION BETWEEN TINS SCORE OUTCOME

Trauma Infant Neurological Score (TINS) as a Prognostic Factor and Guideline for CT Scan in Infants 24 Months Old or Less

Start date: April 2016
Phase: N/A
Study type: Observational [Patient Registry]

Traumatic brain injury (TBI) is the major cause of disability and death among the younger population. In the Pediatric population Head trauma may be responsible for primary and secondary brain damage. Primary brain injury results from a direct mechanical damage at the time of injury, whereas secondary injury is caused by further cellular damage that develops hours or days post injury. Intracranial Injury in Infants (III) may be hard to diagnose in the abcence of neurological deficit or early deterioration. On the other hand, symptoms such as vomiting and restlessness may be present even in the case of minor head injury, and unnesessary scaning (CT) may be performed in many centers just because clinical judgment is problematic in this particular age. Some intracranial injuries may be imminent, such as evolving Epidural hematoma (EDH) in infants, and early diagnosis may be lifesaving and leading to excellent outcome. In adults, GCS has been accepted as the most usuful tool for emergency evaluation of head injured patients. In children, several scores were introduced, including the Children's Coma Score (CCS), however they have been found problematic to use in the very young population, since accurate evaluation of communication in CCS is hard, and there is insufficient relevant parameters uncorporated into the score that may have significant importance in this particular age group. In TINS (Trauma Infant Neurological Score) we characterized the clinical parameters and the mechanism of trauma in a simplified method. As previously published, this score has been used by us and by other groups, in retrospective studies. Still, in the lack of prospective studies using TINS, there are no optimal guidelines to perform computed tomography (CT) in this unique population, and TINS has not prospectively been challenged as a predictor tool for outcome. In this prospective study we will approach these issues.

NCT ID: NCT02731573 Completed - Clinical trials for Postoperative Wound Infection Deep Incisional Surgical Site

Safety and Efficacy of D-PLEX in the Prevention of Sternal Infection Post Cardiac Surgery

Start date: October 2016
Phase: Phase 1/Phase 2
Study type: Interventional

This study is aimed to assess the anti-infective efficacy of D-PLEX over a period of 3 months post operation as well as the safety over a period of 6 months, by preventing sternal infection post cardiac surgery in patients above the age of 18, including high risk patients for infection. This study is a 2 parts study: part 1 is a single arm, part 2 is randomized controlled study.

NCT ID: NCT02731209 Recruiting - Clinical trials for Renal Insufficiency, Chronic

Functional Urodynamic Changes in Chronic Kidney Disease Patients and Does Insertion of Urinary Catheter Delay the Need for Kidney Dialysis

Start date: February 2016
Phase: N/A
Study type: Interventional

The aim of the investigators work is to describe the urodynamic results in the CKD (chronic kidney disease) grade 4 patients and to verify observations that urinary catheter may improve kidney function in those patients. 100 patients with CKD grade 4 will do urodynamic examination. All patients will be randomized into two groups / the intervention group that will be inserted urinary catheter for 2 weeks and the follow up group. Kidney function will be monitored by creatinin values and the investigators will measure the time to dialysis in the two groups.

NCT ID: NCT02730806 Enrolling by invitation - Clinical trials for Post-Traumatic Stress Disorders

Treatment of NLP Method in Women Who Have Experienced Postpartum Post Traumatic Stress Dissorder

NLP
Start date: February 27, 2017
Phase: N/A
Study type: Interventional

The purpose of this interventional study is to evaluate the effectiveness of the NLP PTSD protocol in the event of PPPTSD. The study's main hypothesis is that the implementation of the NLP protocol will be effective and result in reduction of the overall PTSD level.

NCT ID: NCT02730299 Active, not recruiting - Lymphoma Clinical Trials

Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS

Start date: December 16, 2016
Phase: Phase 3
Study type: Interventional

This study is an open-label, controlled, multicenter, international, Phase III, randomized study of transplantation of NiCord® versus transplantation of one or two unmanipulated, unrelated cord blood units in patients with acute lymphoblastic leukemia or acute myeloid leukemia, myelodysplastic syndrome, chronic myeloid leukemia or lymphoma, all with required disease features rendering them eligible for allogeneic transplantation.

NCT ID: NCT02728557 Active, not recruiting - Clinical trials for Major Depressive Disorder

Supportive and Supportive-Expressive Treatment for Depression

SSETD
Start date: March 2016
Phase: N/A
Study type: Interventional

This study will assign patients to two types of psychotherapies in treating people with a major depression disorder, expressive versus supportive techniques, and will examine their ability to benefit from treatment based on their attachment orientation. This is a four month protocol, with a year follow up period, will compare patients receiving supportive-expressive treatment with either expressive focus or supportive focus.

NCT ID: NCT02727790 Completed - Clinical trials for Type 2 Diabetes Mellitus

Effect of Short Peripheral Electrical Stimulation (PES) on Blood Glucose

Start date: July 2014
Phase: N/A
Study type: Interventional

The epidemic nature of type 2 diabetes mellitus, along with the downsides of current treatments, has raised the need for therapeutic alternatives. The aim of this study is to evaluate safety, tolerability, and the glucose-lowering effect of noninvasive peripheral electrical stimulation (PES) as an alternative treatment for diabetes.